Honokiol Induces Cell Cycle Arrest and Apoptosis Via Inhibiting Class I Histone Deacetylases in Acute Myeloid Leukemia

Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class Ι histone deacetylases

(2013) Chi-qi Chen et al.   CARCINOGENESIS

Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia

(2012) Chie Ishikawa et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents

(2012) Jürgen Sonnemann et al.   BRITISH JOURNAL OF HAEMATOLOGY

Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy

(2012) S. Arora et al.   CURRENT MOLECULAR MEDICINE

Targeting class I histone deacetylases in cancer therapy

(2012) Geneviève P Delcuve et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Transcription of the AML1/ETO chimera is guided by the P2 promoter of the AML1 gene in the Kasumi-1 cell line

(2012) Elena N. Markova et al.   GENE

Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases

(2011) V. S. Thakur et al.   CARCINOGENESIS

Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2

(2011) J. Zhang et al.   GENES & DEVELOPMENT

Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms

(2011) Vibe Skov et al.   LEUKEMIA & LYMPHOMA

Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model

(2011) Xianhuo Wang et al.   PLoS One

The Ski protein negatively regulates Siah2-mediated HDAC3 degradation

(2010) Hong-Ling Zhao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia

(2010) Daniel Antunes Moreno et al.   BRITISH JOURNAL OF HAEMATOLOGY

Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells

(2010) Lijun Tan et al.   CANCER

Chemopreventive Agent 3,3'-Diindolylmethane Selectively Induces Proteasomal Degradation of Class I Histone Deacetylases

(2010) Y. Li et al.   CANCER RESEARCH

Inhibitors of HDACs - Effective Drugs Against Cancer?

(2010) S. Muller et al.   CURRENT CANCER DRUG TARGETS

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs

(2010) Paul A Marks   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells

(2010) Eun-Taex Oh et al.   INVESTIGATIONAL NEW DRUGS

Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21

(2009) Sefa Kizildag et al.   ANNALS OF HEMATOLOGY

Different Redox States in Malignant and Nonmalignant Esophageal Epithelial Cells and Differential Cytotoxic Responses to Bile Acid and Honokiol

(2009) Gang Chen et al.   ANTIOXIDANTS & REDOX SIGNALING

Clinical Studies of Histone Deacetylase Inhibitors

(2009) H. M. Prince et al.   CLINICAL CANCER RESEARCH

Expression Levels of Histone Deacetylases Determine the Cell Fate of Hematopoietic Progenitors

(2009) Taeko Wada et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Evaluation of magnolia bark extract in chromosomal aberration assays

(2008) Baowei Zhang et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Mechanism for ubiquitylation of the leukemia fusion proteins AML1-ETO and PML-RARα

(2007) Oliver H. Krämer et al.   FASEB JOURNAL